Ads
related to: car t-cell therapy- Clinical Results
Review Clinical Results & Data
OF A 3L+ FL Treatment.
- Contact A Representative
Contact A Rep To Learn More About A
Follicular Lymphoma Therapy Option.
- Financial Support
Get More Info About The Financial
Assistance Options Of A FL Therapy.
- Dosing & Administration
View Dosing & Admin Info To Learn
About Infusion Dosing Options.
- Professional Resources
Download Helpful Resources To
Support Your Patients & Practice.
- Safety Information
View Full Safety Information
For A 3L+ FL Treatment.
- Clinical Results
Search results
Car T-Cell Therapy
WNDU 16 South Bend· 3 days agoMedical experts call it a ‘breakthrough’ and ‘gamechanger’ when it comes to cancer treatment. “Immunotherapy has really come on as quite an advance in...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 6 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
...Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated...
Benzinga· 3 hours agoWednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s BMY Breyanzi...
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThe CD19-directed chimeric antigen receptor (CAR) T cell therapy is indicated for patients who have...
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of...
WPRI Providence· 6 days agoOn May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR ...
Tumor tissue on a chip: New possibilities for cell therapies and personalized medicine
Medical Xpress· 1 day ago"This allows us to individually investigate how exactly these tumor cells react to the planned therapy, what side effects may be expected and how these can be reduced," explains ...
Research explains new method to engineer immune cells that could treat multiple cancer patients
Medical Xpress· 3 hours agoThis novel technology, described in a study published in Nature Biotechnology, marks a major step toward enabling the mass production of cell therapies like CAR-T ...
Earnings call: Fate Therapeutics reports on clinical progress and finances
Investing.com· 4 days agoThe company's FT819 CAR T-cell therapy showed promise for B-cell-mediated autoimmune diseases, with...
Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma
Morningstar· 8 hours agoBristol Myers Squibb has won U.S. Food and Drug Administration expanded approval of its CAR-T cell therapy Breyanzi ...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 2 hours agoUpdates from BMY: Bristol Myers BMY announced that the FDA had granted accelerated approval to the...